Keywords: king, 3rd-qtr, profit, plunges, may, restate, pharmaceuticals

King's 3rd-qtr profit plunges, may restate

Article | 08 November 2004

King Pharmaceuticals of the USA reported a 74% dive in third-quarter 2004 earnings to $27.6 million, or $0.11 per share, and said that it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in